urinary di(2-ethylhexyl) phthalate (dehp) metabolite concentrations increased unexpectedly from a median of 283.7 nmol/g at baseline to 7027.5 nmol/g during the intervention (p<0.0001) among arm 1 participants, and no significant changes were observed for arm 2 participants.